AstraZeneca
Health Minister Constantinos Ioannou on Wednesday called for action by the EU to make sure AstraZeneca treats the bloc the same way as its other...
Aussie scientists raise doubts over vaccine efficacy of AstraZeneca
Australian scientists have raised questions over the efficacy of the AstraZeneca COVID-19 vaccine in establishing herd immunity, calling for a pause on its widespread rollout...
EU drugs watchdog receives Astra-Oxford vaccine approval application (Update)
The European medicines regulator said on Tuesday it had received an application from AstraZeneca for the conditional approval of the drugmaker’s COVID-19 vaccine being developed...
Coronavirus: Cyprus expects 600,000 AstraZeneca vaccines, awaiting EMA approval
The health ministry on Thursday published an update from the European Medicines Agency (EMA), the body in charge of the evaluation of medicinal products, on...
AstraZeneca Covid-19 vaccine can be 90% effective
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil...
Oxford COVID-19 vaccine trials produce robust immune response in elderly (update)
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were...
EU signs contract with AstraZeneca on supply of potential COVID-19 vaccine
The European Commission said on Thursday it had signed a contract on behalf of EU states with British drugmaker AstraZeneca for the supply of at...
Coronavirus: Ministry says Cyprus will need 1.2 million vaccines (updated)
By Evie Andreou and Annette Chrysostomou Cyprus has already informed the EU it would need 1.2 million Covid-19 vaccines, to also cover the Turkish Cypriot...
AstraZeneca agrees to supply Europe with 400m doses of COVID-19 vaccine
AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal...